Clinical Trials Browser

Leukemia, Myelomonocytic, Chronic × bisantrene × Clear all

NCT05456269 2023-10-03

BISECT

Phase 1 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic